Alerts will be sent to your verified email
Verify Email
SAMRATPH
|
Samrat Pharmachem
|
Phaarmasia
|
Zenith Drugs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
18.86 % | 0.46 % | 19.81 % |
|
5yr average Equity Multiplier
|
1.83 | 2.3 | 3.92 |
|
5yr Average Asset Turnover Ratio
|
2.61 | 0.96 | 1.08 |
|
5yr Avg Net Profit Margin
|
3.87 % | -4.04 % | 5.08 % |
|
Price to Book
|
0.92 | 5.96 | 0.0 |
|
P/E
|
0.0 | 3.62 | 9.34 |
|
5yr Avg Cash Conversion Cycle
|
58.79 Days | -236.72 Days | -5.9 Days |
|
Inventory Days
|
28.98 Days | 79.69 Days | 59.46 Days |
|
Days Receivable
|
80.32 Days | 83.55 Days | 153.74 Days |
|
Days Payable
|
46.76 Days | 340.86 Days | 283.33 Days |
|
5yr Average Interest Coverage Ratio
|
16.47 | -92.68 | 3.87 |
|
5yr Avg ROCE
|
27.43 % | -8.87 % | 26.61 % |
|
5yr Avg Operating Profit Margin
|
5.58 % | -5.39 % | 9.63 % |
|
5 yr average Debt to Equity
|
0.21 | 0.0 | 1.03 |
|
5yr CAGR Net Profit
|
5.93 % | n/a | 17.92 % |
|
5yr Average Return on Assets
|
10.3 % | -3.86 % | 5.28 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
49.09 % | 73.51 % | 69.98 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.45 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Samrat Pharmachem
|
Phaarmasia
|
Zenith Drugs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|